More Rhythm Biosciences Limited news
Rhythm Biosciences LimitedASX: RHY

Rhythm Advances ColoSTAT Study 7

Jan 18, 2021 at 7:27 PM EST · Issued by Rhythm Biosciences Limited

Filed with ASX · Jan 18, 2021 at 7:27 PM EST

On 6ix: 6ix.com/news/rhythm-advances-colostat-study-7

Rhythm Biosciences Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Rhythm Biosciences Limited on 6ix

Earlier from Rhythm Biosciences

  • Investor Presentation - December 2020Dec 20, 2020
  • Rhythm Secures US Patent - Strengthens Global FootprintDec 16, 2020
  • Rhythm Appoints Global Manufacturer for ColoSTATDec 1, 2020
  • AGM Presentation - November 2020Nov 17, 2020
  • ColoSTAT Prototype Complete, Outperforms FITNov 11, 2020

Later from Rhythm Biosciences

  • Initial Manufacturing of ColoSTAT Test-Kits CompleteJan 19, 2021
  • Rhythm Expands ColoSTAT Clinical Trial To Tenth SiteFeb 10, 2021
  • Study 6 Successfully Concluded - Exceptional ResultsMar 15, 2021
  • Rhythm Retains ISO13485 CertificationMar 30, 2021
  • Rhythm Extends ColoSTAT Clinical Trial to Western AustraliaApr 12, 2021
All Rhythm Biosciences news releases↗

Follow Rhythm Biosciences into a list and get an email when it puts out news.

Follow Rhythm Biosciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer